Company Phoenix Life Sciences International Limited
Equities
PLSI
US71910Q1022
Pharmaceuticals
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 25/14/25 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 25/14/25 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,084,582 | 8,644,192 ( 85.72 %) | 0 | 85.72 % |
Company contact information
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coSector
1st Jan change | Capi. | |
---|---|---|
+46.06% | 75TCr | |
+40.95% | 63TCr | |
-5.87% | 35TCr | |
+19.84% | 33TCr | |
+9.52% | 30TCr | |
+18.45% | 25TCr | |
+11.88% | 22TCr | |
-0.78% | 22TCr | |
+6.01% | 16TCr |